ArticleHawai'i journal of health & social welfare2026
Investigating HPV Vaccination in the Republic of Palau: Assessment of the School-Based Program from 2020 to 2024.
Article in Hawai'i journal of health & social welfare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer, caused primarily by human papillomavirus (HPV), causes substantial health burden in the Republic of Palau. Despite availability of the HPV vaccine through a school-based vaccination program for girls beginning in 5th grade, HPV vaccination coverage in Palau has declined since 2020. To understand why, this descriptive cross-sectional study analyzed data from the first opportunity for vaccination for all 5th grade girls enrolled at Koror and Babelthaob schools between August 1, 2020 and June 30, 2024. Data were retrieved from the Ministry of Education, School Health Program, and national Immunization Information System (IIS). The proportion of 5th grade girls who returned the consent form, responses to the HPV vaccine consent question, and vaccination coverage with at least 1 dose were analyzed. Among girls enrolled in Palau elementary schools during the period (n=467), although most consent forms were returned (n=434, 93%) and most girls (n=326, 70%) received consent for HPV vaccination, only 42% (n=198) received at least 1 dose of HPV vaccine according to IIS. Responses were missing for the HPV vaccine consent question on 17% of returned forms (n=73). Refusal of the vaccine was uncommon on returned forms (n=35, 8%), but there was an increase in refusals in the latest school year (n=25, 24% of 2023-2024 returned forms). An investigation into the process from the consent form to vaccination outreach in the schools is needed to understand why girls who received consent for vaccination did not receive the vaccine according to IIS. Improving the school-based vaccination program is critical to achieve 90% HPV vaccination coverage and reduce the cervical cancer burden in Palau.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.